Your browser doesn't support javascript.
loading
Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.
St Germain, Diane; Denicoff, Andrea; Torres, Andrea; Kelaghan, Joseph; McCaskill-Stevens, Worta; Mishkin, Grace; O'Mara, Ann; Minasian, Lori M.
Affiliation
  • St Germain D; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Denicoff A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • Torres A; Health, Environment, Analytics, Resilience & Social Group, ICF, Fairfax, Virginia.
  • Kelaghan J; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • McCaskill-Stevens W; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Mishkin G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
  • O'Mara A; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Minasian LM; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
Cancer ; 126(11): 2687-2693, 2020 06 01.
Article in En | MEDLINE | ID: mdl-32237256
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Clinical Trials as Topic / Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Clinical Trials as Topic / Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Year: 2020 Type: Article